消炎利胆片联合经皮肝穿刺胆道镜碎石取石术在胆石症治疗中的应用效果  

Application effect of Inflammation-Resolving Gall-Bladder-Excreting Tablets combined with percutaneous transhepatic cholangioscopy lithotripsy in the treatment of cholelithiasis

作　　者：江志沅 王三贵 高莲香 刘志平 李小青 JIANG Zhi-yuan;WANG San-gui;GAO Lian-xiang;LIU Zhi-ping;LI Xiao-qing(Department of Surgery, Nancheng Hospital of Dongguan City, Guangdong Province, Dongguan 523071, China)

机构地区：[1]广东省东莞市南城医院外科,广东东莞523071

出　　处：《中国当代医药》2019年第7期29-31,共3页China Modern Medicine

基　　金：广东省东莞市社会科技发展项目(201750715008248)

摘　　要：目的探讨消炎利胆片联合经皮肝穿刺胆道镜碎石取石术在胆石症治疗中的应用效果。方法选取2017年4月～2018年4月我院收治的80例胆石症患者作为研究对象,根据随机数字表法分为观察组和对照组,每组各40例。对照组仅接受经皮肝穿刺胆道镜碎石取石术治疗,观察组接受消炎利胆片+经皮肝穿刺胆道镜碎石取石术治疗。比较两组术后的并发症发生情况、结石复发率,同时评估和比较两组术前与术后6个月的中医症状评分。结果观察组术后的并发症总发生率为7.50%,显著低于对照组的27.50%,差异有统计学意义(P<0.05);观察组术后无复发,显著低于对照组的10.00%,差异有统计学意义(P<0.05);观察组术后6个月的中医症状评分显著低于对照组,差异有统计学意义(P<0.05)。结论在胆石症患者治疗中,应用消炎利胆片联合经皮肝穿刺胆道镜碎石取石术治疗,在改善患者中医症状评分与降低结石复发率方面效果显著,值得推广应用。Objective To explore the effect of Inflammation-Resolving Gall-Bladder-Excreting Tablets combined with percutaneous transhepatic cholangioscopy lithotripsy in the treatment of cholelithiasis. Methods Eighty patients with cholelithiasis admitted to our hospital from April 2017 to April 2018 were selected as the research objects, according to the random number table method, they were divided into observation group and control group, with 40 cases in each group. The control group received only percutaneous transhepatic cholangioscopy lithotripsy, while the observation group received Inflammation-Resolving Gall-Bladder-Excreting Tablets plus percutaneous transhepatic cholangioscopy lithotripsy. The incidence of complications and recurrence rate of stones were compared between the two groups, and the scores of TCM symptoms before and 6 months after operation were evaluated and compared. Results The total incidence of complications after operation in the observation group was 7.50%, which was significantly lower than 27.50% in the control group, the difference was significant (P<0.05). There was no recurrence in the observation group after operation, which was significantly lower than 10.00% in the control group, the difference was significant (P<0.05). The scores of TCM symptoms at 6 months after operation in the observation group were significantly lower than those in the control group, the difference was significant (P<0.05). Conclusion In the treatment of patients with cholelithiasis, Inflammation-Resolving Gall-Bladder-Excreting Tablets combined with percutaneous transhepatic cholangioscopy lithotripsy for the treatment of cholelithiasis has achieved remarkable results in improving the scores of TCM symptoms of patients and reducing the recurrence rate of stones, which is worthy of popularization and application.

关 键 词：消炎利胆片 经皮肝穿刺胆道镜碎石取石术 胆石症 

分 类 号：R575.62[医药卫生—消化系统]